DCGI asks Wockhardt, Ranbaxy to explain lapses

Generics |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 02 Sep, 2013

Singapore: The Indian Drug Controller General of India (DCGI) has written a letter to the drug maker Wockhardt to explai...Read more

Dr. Reddy's launches generic psychiatric drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Aug, 2013

Singapore: Dr. Reddy's Laboratories has launched drug for psychiatric conditions, Divalproex Sodium extended release tab...Read more

Strides gets tentative FDA nod for HIV generic

Generics |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 02 Aug, 2013

Singapore: FDA has granted tentative approval to India-based Strides Arcolab's HIV drug emtricitabine and tenofovir diso...Read more

GSK hit by more bribery allegations in China

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

Singapore: Days after a probe was initiated by the Chinese police into alleged 'economic crimes' committed by senior off...Read more

Ranbaxy launches generic of Pioglitazone in US

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2012

Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has launched authorized generic ...Read more

Abbott rejigs strategy, realigns India business

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

Singapore: After acquiring the formulations business of India's Piramal Healthcare in 2010, US drug major Abbott Laborat...Read more

Chinese medicine firm Tianyin gets GMP certificate

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

Singapore: China-based Tianyin Pharmaceutical (TPI) received GMP certification for its pre-extraction plant and formula...Read more

Natco wins patent dispute case against Teva

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Mar, 2014

Singapore: Based in India's Hyderabad, drug manufacturing major Natco Pharmaceuticals has won a long standing patent dis...Read more

Lilly to expand generics manufacturing facility in China

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2014

Singapore: Lilly and Novast Laboratories have commenced the expansion of manufacturing and development facility capaciti...Read more

Ranbaxy to market infliximab biosimilar

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2014

Singapore: Switzerland based EPIRUS, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, and Ranbaxy La...Read more

US FDA issues API bulk & tapped density guidance

Generics |  Regulatory | By BioSpectrum Bureau  | 3 Comment | 11 Jul, 2013

Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industr...Read more

Teva gets FDA nod for generics of Eli Lillys Evista

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2014

Singapore: Teva Pharmaceutical has recieved USFDA approval of the generic equivalent to Evista (Raloxifene) Tablets, 60 ...Read more

Sun Pharma revenue touches $480 million in Q2 2012

Generics |  Company results | By BioSpectrum Bureau  | 9 Comment | 10 Aug, 2012

Mumbai: Sun Pharmaceutical Industries reported a growth of 62 percent in its net sales for the quarter ending June 30, 2...Read more

FIPB clears seven pharma proposals, defers three

Generics |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 08 Jul, 2013

Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the ph...Read more

Australia temporarily bans 19 synthetic drugs

Generics |  Regulatory | By BioSpectrum Bureau  | 3 Comment | 21 Jun, 2013

Singapore: The Australian government has imposed a temporary ban on sales of 19 synthetic drugs pursuant to the product ...Read more

Generics market to touch $231 bn by 2017: Report

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 04 Jun, 2012

Singapore: The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to t...Read more

Bayer to acquire China's OTC firm

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2014

Singapore: Bayer plans to acquire 100 percent of the shares of Dihon Pharmaceutical, a privately held pharmaceutical com...Read more

Actavis clocks $8.7 bn revenue in 2013

Generics |  Company results | By BioSpectrum Bureau  | 0 Comment | 21 Feb, 2014

Singapore: Global pharmaceutical company Actavis has clocked net revenue of $8.7 billion in the year 2013, marking an in...Read more